Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Zhimeng Biopharma's CB03 Granted Orphan Drug Status by the US FDA for Amyotrophic Lateral Sclerosis as a Potassium Ion Channel Opener
Saturday, October 21, 2023Shanghai Zhimeng Biopharma Inc has recently announced that their innovative smallmolecule compound known as CB which selectively activates KCNQ channels has been granted orphan drug designation
China Nmpa Approves Skyline Therapeutics SKG0106 for Neovascular Age-related Macular Degeneration Gene Therapy
Friday, October 20, 2023Skyline Therapeutics an innovative gene therapy company focused on developing novel solutions for rare and severe diseases has announced that the China National Medical Products Administration has granted approval
Endeavor BioMedicines Acquires Global Rights to HMBD-501, a Next-Generation HER3-Targeted Antibody-Drug Conjugate (ADC) in Licensing Agreement with Hummingbird Bioscience
Friday, October 20, 2023Hummingbird Bioscience and Endeavor BioMedicines jointly announced an agreement in which Endeavor will acquire the exclusive global rights to Hummingbird Bios antibodydrug
FDA Grants Approval to Orasis Pharmaceuticals for QLOSI™ in the Management of Presbyopia
Thursday, October 19, 2023Orasis Pharmaceuticals a burgeoning player in the ophthalmic pharmaceutical sector with a goal of revolutionizing vision enhancement proudly announced the US Food and Drug Administration approval of QLOSI
Novavax's COVID-19 Vaccine Nuvaxovid™ Granted Full Approval in Singapore
Thursday, October 19, 2023Novavax Inc has received full approval from the Health Sciences Authority in Singapore for its prototype COVID vaccine Nuvaxovid This approval permits the use of the vaccine for active immunization against COVID
WuXi XDC and HKSTP Partner to Foster Growth in Hong Kong's Bioconjugate Drug Sector
Wednesday, October 18, 2023WuXi XDC a leading global Contract Research Development and Manufacturing Organization specializing in the field of AntibodyDrug Conjugates and the broader bioconjugate market
Elevar Therapeutics and Jiangsu Hengrui Pharma Partner for Worldwide Licensing of Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma
Wednesday, October 18, 2023Elevar Therapeutics Inc a biopharmaceutical company majorityowned by HLB Co Ltd has entered into a global licensing agreement with Jiangsu Hengrui Pharmaceuticals Co Ltd one of Chinas leading pharmaceutical companies
Ideaya Biosciences Announces Phase 2 Expansion for Darovasertib and Crizotinib Combination in GNAQ/11 Mutated Metastatic Cutaneous Melanoma
Tuesday, October 17, 2023IDEAYA Biosciences Inc a company specializing in precision medicine for oncology has announced the commencement of a Phase expansion for the combination of darovasertib and crizotinib in the treatment of GNAQ
Ascentage Pharma and Astrazeneca Collaborate on Phase III Study for First-line CLL/SLL Treatment With Bcl-2 Inhibitor Lisaftoclax and BTK Inhibitor Acalabrutinib
Monday, October 16, 2023Ascentage Pharma HK a global biopharmaceutical company dedicated to developing novel therapies for cancer chronic hepatitis B CHB and agerelated diseases
Foresee Pharmaceuticals Advances Phase 3 Trial for Leuprolide (Fp-001) in Central Precocious Puberty"
Saturday, October 14, 2023Foresee Pharmaceuticals has officially launched the Casppian Phase registration study marking the administration of the initial patient dose
